Condition
Mortality Through Six Months of Age
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Vitamin A Supplementation 15000 Ug Retinol Equivalents Or 50000 Iu
Research Leaders
6 sponsors active, led by Bill and Melinda Gates Foundation
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Vitamin A Supplementation 15000 Ug Retinol Equivalents Or 50000 Iu1
Active Sponsors
- Bill and Melinda Gates Foundation1
- Access Business Group1
- Canadian International Development Agency1
- Johns Hopkins Bloomberg School of Public Health1
- Johns Hopkins University1
Top Investigators
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health
Related Conditions
- Vitamin A Deficiency1